National charity Epilepsy Action has committed £150,000 to fund three new epilepsy specialist nurse posts in Wales. The charity announces its plans following today’s launch of the Service Development Directive for Epilepsy by the Welsh Assembly Government. The directive, which is the first of...
Epilepsy Charity Pledges Funds For Vital New Nurse Posts In Wales
Ending Epileptic Seizures
One in ten people will suffer from a seizure in their life and many of those will be diagnosed with epilepsy. Medication will help approximately two-thirds of the people with epilepsy, but many continue to have seizures, even though there are other alternatives. “Epilepsy ended my teaching career,”...
New Keppra XR(TM) Data Highlight Its Role For Patients With Partial-Onset Seizures
UCB announced findings from new studies of the once-daily antiepileptic drug (AED) Keppra XR(TM) (levetiracetam) extended-release tablets comparing tolerability versus levetiracetam immediate release (IR) and reporting on additional dosing schedules. The data were among five studies that were presented...
Anti-Seizure Medication Can Safely Be Withdrawn From Children With Epilepsy
A new Mayo Clinic study found that it is generally safe to withdraw anti-seizure medications in children with epilepsy who have achieved seizure-freedom while on the medication. Researchers found that these children were not at high risk of subsequently developing intractable epilepsy. The study was...
Efficacy Of New Seizure Screening Algorithm - Positive Data On Novel Neurodiagnostic Technology
A study by researchers at the Johns Hopkins University School of Medicine reports that a new seizure diagnostics algorithm developed by Baltimore-based Infinite Biomedical Technologies (IBT) accurately screens patients with nonconvulsive seizures. The algorithm is part of a comprehensive neurodiagnostic...
Beyond Seizure Control In The Treatment Of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM)
Data Highlight The Efficacy, Safety and Significant Improvement in Quality of Life and Depressive Symptoms With Zebinix(TM) (Eslicarbazepine Acetate) Positive data from three phase III studies presented at the American Epilepsy Society (AES) Congress, Seattle, USA, show that Zebinix(TM)(1) (eslicarbazepine...
NIH Grant Awarded To Jefferson Researcher Studying Antiepileptic Seizure Medications.
Scott Mintzer, M.D., assistant professor in the Department of Neurology at Jefferson Medical College of Thomas Jefferson University, and director of the Epilepsy Monitoring Unit at the Jefferson Comprehensive Epilepsy Center of Jefferson Hospital for Neuroscience was recently awarded a Junior Investigator...
USP Transitions Medication Error Reporting Programs
In a decision to focus full attention and resources on its core standards-setting activities, USP will transfer its reporting programs, MEDMARX® and the Medication Errors Reporting (MER) Program, to Quantros and the Institute for Safe Medication Practices (ISMP), respectively. This decision in no way...
New Target Discovered To Treat Epileptic Seizures Following Brain Trauma Or Stroke
New therapies for some forms of epilepsy may soon be possible, thanks to a discovery made by a team of University of British Columbia and Vancouver Coastal Health Research Institute neuroscience researchers. The researchers found that hemichannels - the same channels the researchers previously found...
Epilepsy Drug May Increase Risk Of Autism In Children
A new study shows that women who take the epilepsy drug valproate while pregnant may significantly increase their child’s risk of developing autism. The preliminary research is published in the December 2, 2008, print issue of Neurology®, the medical journal of the American Academy of Neurology. The...